Download Gregory S. Cooper, MD Biosketch

Principal Investigator/Program Director (Last, First, Middle):
BIOGRAPHICAL SKETCH
Provide the following information for the key personnel and other significant contributors in the order listed on Form Page 2.
Follow this format for each person. DO NOT EXCEED FOUR PAGES.
NAME
POSITION TITLE
Cooper, Gregory S.
Professor
eRA COMMONS USER NAME
GCOOPER
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.)
INSTITUTION AND LOCATION
DEGREE
(if applicable)
YEAR(s)
BA
MA
MD
1982
1982
1986
University of Pennsylvania, Philadelphia, PA
University of Pennsylvania, Philadelphia, PA
University of Pennsylvania, Philadelphia, PA
A.
FIELD OF STUDY
Sociology
Sociology
Medicine
Positions and Honors
1986-1989 Medical Resident, University Hospitals of Cleveland (UHC), Case Western Reserve University
(CWRU), Cleveland, OH
1989-1991 Gastroenterology Fellow, UHC and CWRU, Cleveland, OH
1991-1992 Chief Medical Resident, UHC and CWRU, Cleveland, OH
1992-1993 Clinical Epidemiology and Gastroenterology Fellow, UHC and CWRU, Cleveland, OH
1993-1994 Assistant Professor of Medicine, CWRU and UHC, Cleveland, OH
1994-1996 Assistant Professor of Medicine and General Medical Sciences (Oncology), CWRU and UHC,
Cleveland, OH
1994Member, Case Comprehensive Cancer Center, Cleveland, OH
1996-1999 Assistant Professor, Medicine and Epidemiology & Biostatistics, CWRU and UHC, Cleveland, OH
1999-2005 Associate Professor of Medicine-Gastroenterology, General Medical Sciences (Oncology) and
Epidemiology & Biostatistics, CWRU and UHC, Cleveland, OH
2005Professor of Medicine-Gastroenterology, General Medical Sciences (Oncology) and Epidemiology
& Biostatistics, CWRU and UHC, Cleveland, OH
2006Co-Leader, Cancer Prevention, Control and Population Research Program, Case Comprehensive
Cancer Center, Cleveland, OH
2011Director, Office of Comparative Effectiveness Research, Case Clinical Translational Science
Collaborative (CTSC), Cleveland, OH
Honors and Awards:
2005 John Peter Minton Hero of Hope Research Medal of Honor from the American Cancer Society, Ohio
Division
Study Sections
2006- 2012 American Cancer Society: Cancer Control and Prevention: Health Policy and Health Services
Research
2009- National Institutes of Health: Health Services Organization and Delivery(HSOD) Study Section, Ad Hoc
Reviewer
2009- American College of Gastroenterology : Research Committee
Advisory Boards
2012- University of Arizona Cancer Center External Scientific Advisory Board
2012- Columbia University Cancer Center External Scientific Advisory Board
B.
Selected peer-reviewed publications (selected 2000-present)
Cummings KC 3rd, Xu F, Cummings LC, Cooper GS. A comparison of epidural analgesia and traditional pain
management effects on survival and cancer recurrence after colectomy: a population-based study.
Anesthesiology 2012; 116:797-806.
PHS 398/2590 (Rev. 11/07)
Page
Biographical Sketch Format Page
Principal Investigator/Program Director (Last, First, Middle):
Cummings LC, Delaney CP, Cooper GS: Laparosopic versus open colectomy for colon cancer in an older
population: a cohort study. World J Surg Oncol 2012: 10:31.
Greer KB, Thompson CL, Brenner L, Bednarchik B, Dawson D, Willis J, Grady WM, Falk GW, Cooper GS, Li L,
Chak A. Association of insulin and insulin-like growth factors with Barrett's oesophagus. Gut. 2012;
61:665-72.
Cooper GS, Kou TD, Barnholtz-Sloan JS, Koroukian SM, Schluchter MD: Use of colonoscopy for polyp
surveillance in Medicare beneficiaries. Cancer (accepted for publication).
Cooper GS, Kou TD, Rex DK: Complications following colonoscopy with anesthesia assistance: a populationbased analysis. JAMA Intern Med (accepted for publication).
Additional Peer Review Publications Relevant to the Field
(10)
Cooper GS, Kou TD, Reynolds HL Jr. Receipt of guideline-recommended follow-up in older colorectal cancer
survivors: a population-based analysis. Cancer 113:2029-2037, 2008.
Cooper GS, Kou TD, Wong RC. Outpatient management of nonvariceal upper gastrointestinal hemorrhage:
unexpected mortality in Medicare beneficiaries. Gastroenterology 136:108-114, 2009.
Cooper GS, Kou TD, Chak A: Receipt of previous diagnoses and endoscopy and outcome from esophageal
adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol 2009; 104:1356-62.
Mines D, Gu Y, Kou TD, Cooper GS: Recombinant human bone morphogenic protein-2 and pancreatic cancer:
a retrospective cohort study. Pharmacoepid Drug Safety 2011; 20:111-8.
Kouroukian SM, Bakaki P, Beaird H, Earle C, Cooper GS: Cancer stage comparison between dual MedicareMedicaid eligibles using Medicaid as a supplemental health insurance program and low-income non-duals.
J Public Health Manag Pract 2011; 17:479-91.
Flocke SA, Stange KC, Cooper GS, Wunderlich TL, Oja-Tebbe N, Divine G, Lafata JE. Patient-rated
importance and receipt of information for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev
20:2168-2173, 2011.
Koroukian SM, Bakaki PM, Owusu C, Earle CC, Cooper GS: Cancer outcomes in low-income elders: Is there
an advantage to being on Medicaid? Medicare Care Medicaid Research Review 2012; 2:E1–E22.
Dor A, Koroukian SM, Xu F, Stulberg JJ, Delaney CP, Cooper GS: Pricing of surgeries for colon cancer:
patient severity and market factors. Cancer 2012; 118:5741-8.
Cooper GS, Xu F, Barnholtz Sloan JS, Koroukian SM, Schluchter MD: Management of malignant colon polyps:
a population-based analysis of colonoscopic polypectomy versus surgery. Cancer 2012; 118:651-9
Cooper GS, Xu F, Barnholtz Sloan JS, Schluchter MD, Koroukian SM: Prevalence and predictors of interval
colorectal cancers in Medicare beneficiaries. Cancer 2012, Cancer 2012; 118:3044-52.
C.
Research Support.
ACTIVE
1R01 CA132862-01 (Cooper, PI)
01/01/09-12/31/11 (NCE through 12/31/13)
NIH/NCI
Colonoscopy: Practice Patterns and Limitations
Colorectal cancer, the second most fatal cancer in the U.S., is largely preventable through the removal
of polyps. However, there is only limited knowledge about the treatment and outcome of colorectal polyps in
routine clinical practice. Using data from a large number of Medicare patients, we will study practice patterns
for polyp removal via colonoscopy, evaluate its effectiveness in the treatment of early stage colorectal cancer,
and estimate the potential failed detection rate at colonoscopy.
1P50CA150964 (Markowitz, PI; Cooper, Co-Project Leader)
9/1/12-8/31/17
NIH/NCI
Case GI SPORE
Detection of Advanced Adenomas via Stool DNA (sDNA) Methylation Testing
The goal of this project is to evaluate the accuracy of a panel of stool DNA methylation markers in
detection of advanced polyps in a screening population, including the management of apparent false positive
tests.
RSGI-12-218-01-CPHPS (Cooper, PI)
American Cancer Society
PHS 398/2590 (Rev. 11/07)
7/1/12-6/30/14
Page
Continuation Format Page
Principal Investigator/Program Director (Last, First, Middle):
Healthcare Reform and Cancer Screening
The goals of this proposal are to evaluate the use of screening mammography, colonoscopy and PSA
testing in Medicare beneficiaries before and after the Affordable Care Act legislation and to determine variation
in procedure use according to patient and regional characteristics.
5P30 CA043703-22 (Gerson, PI)
09/30/91-03/31/13
NIH/NCI
Comprehensive Cancer Center Support Grant
The objectives of the Center are: 1) to improve the prevention, diagnosis, and therapy of cancer
through research; 2) to stimulate and support innovative, coordinated, interdisciplinary research on cancer
diagnosis, treatment, and control; 3) to develop clinical applications of research discoveries and to make these
applications available as quickly as possible; and 4) to develop cancer prevention and control activities to
contribute to the reduction of cancer morbidity and mortality in Northeast Ohio and the surrounding region and
nation. Role: Leader of Cancer Prevention, Control and Population Research Program
1R01 CA129766-01 (Dor, PI)
7/1/09-6/30/12 (NCE through 6/30/13)
NIH/NCI
The Pricing of Major Cancer Surgeries: Impact of Insurance, Outcomes and Severity
The overall aim of this proposal is to investigate price variations for selected cancer surgical treatments
and to evaluate the degree to which managed care and other forms of insurance are able to capture discounts
from hospitals in the medical marketplace. Role: Site PI
UL1TR000439 (Davis, PI)
6/29/12-5/31/17
NIN/NCATS
Clinical and Translational Science Collaborative of Cleveland
The support will establish the Office of Comparative Effectiveness Research at the Case CTSC and
serve as a resource for education and research support.
Research Scholar Grant (Koroukian, PI)
1/1/12-12/31/13
American Cancer Society
Multilevel Evaluation of Breast Cancer Prevention Efforts in Ohio
The study will specifically examine transitions between the Breast and Cervical Cancer Early Detection
Program, Medicare and Medicaid, will include surveys of BCCEDP Directors, and will consider both countyspecific factors and individual factors on stage of breast cancer diagnosis, treatment received and survival.
Role: Co-Investigator
Medtronic, Inc. (Cooper, PI)
10/1/12-9/30/13
Investigator Initiated Research Contract)
Recombinant human Bone Morphogenic Protein- (rhBMP-2) and Cancer Risk: A Retrospective Cohort Study in
Medicare Beneficiaries
The aim of this study is to determine cancer risk among patients administered rhBMP-2 at the time of
lumbar spinal fusion surgery.
PHS 398/2590 (Rev. 11/07)
Page
Continuation Format Page